Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies.

Hernandez C, Arasanz H, Chocarro L, Bocanegra A, Zuazo M, Fernandez-Hinojal G, Blanco E, Vera R, Escors D, Kochan G.

Int J Mol Sci. 2020 Mar 31;21(7). pii: E2411. doi: 10.3390/ijms21072411. Review.

2.

Transcatheter aortic valve replacement with the balloon-expandable SAPIEN 3 valve: Impact of calcium score on valve performance and clinical outcomes.

Guimarães L, Ferreira-Neto AN, Urena M, Nombela-Franco L, Wintzer-Wehekind J, Levesque MH, Himbert D, Fischer Q, Armijo G, Vera R, Kalavrouziotis D, Rodés-Cabau J.

Int J Cardiol. 2020 Feb 19. pii: S0167-5273(19)35596-2. doi: 10.1016/j.ijcard.2020.02.047. [Epub ahead of print]

PMID:
32139241
3.

Left ventricular unloading during extracorporeal membrane oxygenation - Impella versus atrial septal defect: A simulation study.

Di Molfetta A, Adachi I, Ferrari G, Gagliardi MG, Perri G, Iacobelli R, Qureshi AM, Di Pasquale L, Vera RZ, Guccione P, Di Molfetta M, Chiariello GA, Filippelli S, Amodeo A.

Int J Artif Organs. 2020 Feb 22:391398820906840. doi: 10.1177/0391398820906840. [Epub ahead of print]

PMID:
32089039
4.

Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-panitumumab in first-line (BEYOND).

Aparicio J, Virgili A, Capdevila J, Muñoz Boza F, Álvarez R, Bosch C, Cámara J, Fernandez-Martos C, Fernandez-Plana J, Gallego J, Gallego R, Hernández-Yagüe X, Macías Declara I, Rodríguez-Salas N, Vera R, Taberner M, Maurel J.

Ann Oncol. 2019 Jul;30 Suppl 4:iv52. doi: 10.1093/annonc/mdz155.190. Epub 2019 Dec 4. No abstract available.

PMID:
32085197
5.

Sex Differences in Long-Term Outcomes in Patients With Deferred Revascularization Following Fractional Flow Reserve Assessment: International Collaboration Registry of Comprehensive Physiologic Evaluation.

Hoshino M, Hamaya R, Kanaji Y, Kanno Y, Hada M, Yamaguchi M, Sumino Y, Hirano H, Horie T, Usui E, Sugiyama T, Murai T, Lee T, Yonetsu T, Lee JM, Choi KH, Hwang D, Park J, Jung JH, Kim HY, Jung HW, Cho YK, Yoon HJ, Song YB, Hahn JY, Doh JH, Nam CW, Shin ES, Hur SH, Mejía-Rentería H, Lauri F, Goto S, Macaya F, McInerney A, Gravina G, Vera R, Gonzalo N, Jimenez-Quevedo P, Nuñez-Gil I, Salinas P, Nombela-Franco L, Del Trigo M, Fernández-Ortiz A, Macaya C, Koo BK, Escaned J, Kakuta T.

J Am Heart Assoc. 2020 Feb 18;9(4):e014458. doi: 10.1161/JAHA.119.014458. Epub 2020 Feb 17.

6.

Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?

Vera R, Mata E, González E, Juez I, Alonso V, Iranzo P, Martínez NP, López C, Cabrera JM, Safont MJ, Ruiz-Casado A, Salgado M, González B, Escudero P, Rivera F, Pericay C.

Int J Colorectal Dis. 2020 Apr;35(4):739-746. doi: 10.1007/s00384-020-03509-x. Epub 2020 Feb 15.

PMID:
32062727
7.

The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407).

Grande E, Teulé A, Alonso-Gordoa T, Jiménez-Fonseca P, Benavent M, Capdevila J, Custodio A, Vera R, Munarriz J, La Casta A, Díez JJ, Gajate P, Molina-Cerrillo J, Matos I, Cristóbal EM, Ruffinelli JC, Palacios J, García-Carbonero R.

Oncologist. 2020 Feb 11. doi: 10.1634/theoncologist.2020-0033. [Epub ahead of print]

8.

Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics.

Arasanz H, Zuazo M, Bocanegra A, Gato M, Martínez-Aguillo M, Morilla I, Fernández G, Hernández B, López P, Alberdi N, Hernández C, Chocarro L, Teijeira L, Vera R, Kochan G, Escors D.

Cancers (Basel). 2020 Feb 4;12(2). pii: E344. doi: 10.3390/cancers12020344.

9.

A novel Cyphos IL 104-based polymer inclusion membrane (PIM) probe to mimic biofilm zinc accumulation.

Anticó E, Fontàs C, Vera R, Mostazo G, Salvadó V, Guasch H.

Sci Total Environ. 2020 May 1;715:136938. doi: 10.1016/j.scitotenv.2020.136938. Epub 2020 Jan 25.

PMID:
32032989
10.

Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Remon J, García-Campelo R, de Álava E, Vera R, Rodríguez-Peralto JL, Rodríguez-Lescure Á, Bellosillo B, Garrido P, Rojo F, Álvarez-Alegret R.

Clin Transl Oncol. 2020 Feb 6. doi: 10.1007/s12094-020-02313-x. [Epub ahead of print]

PMID:
32030654
11.

Maintenance treatment in metastatic colorectal cancer: in search of the best strategy.

Ron DA, Vera R, Labandeira CM, Manrique MCA, Núñez MÁ, Cid NG, Mata JG, Montes AF.

Clin Transl Oncol. 2020 Jan 2. doi: 10.1007/s12094-019-02267-9. [Epub ahead of print] Review.

PMID:
31898053
12.

Trends and Drivers of Change of Pastoral Beef Production Systems in a Mediterranean-Temperate Climate Zone of Chile.

Toro-Mujica P, Vera R, Vargas-Bello-Pérez E, Pinedo P, Bas F.

Animals (Basel). 2019 Dec 12;9(12). pii: E1135. doi: 10.3390/ani9121135.

13.

Ocular penetration of fluorometholone-loaded PEG-PLGA nanoparticles functionalized with cell-penetrating peptides.

Gonzalez-Pizarro R, Parrotta G, Vera R, Sánchez-López E, Galindo R, Kjeldsen F, Badia J, Baldoma L, Espina M, García ML.

Nanomedicine (Lond). 2019 Dec;14(23):3089-3104. doi: 10.2217/nnm-2019-0201. Epub 2019 Nov 26.

PMID:
31769335
14.

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Remon J, García-Campelo R, de Álava E, Vera R, Rodríguez-Peralto JL, Rodríguez-Lescure Á, Bellosillo B, Garrido P, Rojo F, Álvarez-Alegret R.

Clin Transl Oncol. 2019 Sep 26. doi: 10.1007/s12094-019-02211-x. [Epub ahead of print] Erratum in: Clin Transl Oncol. 2020 Feb 6;:.

PMID:
31559582
15.

Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial.

Fernández-Martos C, Pericay C, Losa F, García-Carbonero R, Layos L, Rodríguez-Salas N, Martin-Richard M, Alonso-Orduña V, Vera R, Gallego J, Capdevila J, Salud A, Nogué M, Maurel J, Guash I, Montagut C, Lopez C, Macias I, Jain RK, Garcia-Albeniz X.

JAMA Oncol. 2019 Aug 29. doi: 10.1001/jamaoncol.2019.2294. [Epub ahead of print]

PMID:
31465088
16.

Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM.

Vera R, González-Flores E, Rubio C, Urbano J, Valero Camps M, Ciampi-Dopazo JJ, Orcajo Rincón J, Morillo Macías V, Gomez Braco MA, Suarez-Artacho G.

Clin Transl Oncol. 2020 May;22(5):647-662. doi: 10.1007/s12094-019-02182-z. Epub 2019 Jul 29.

PMID:
31359336
17.

Omics Approaches in Pancreatic Adenocarcinoma.

González-Borja I, Viúdez A, Goñi S, Santamaria E, Carrasco-García E, Pérez-Sanz J, Hernández-García I, Sala-Elarre P, Arrazubi V, Oyaga-Iriarte E, Zárate R, Arévalo S, Sayar O, Vera R, Fernández-Irigoyen J.

Cancers (Basel). 2019 Jul 25;11(8). pii: E1052. doi: 10.3390/cancers11081052. Review.

18.

Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.

Alvarez CS, Giménez R, Cañas MA, Vera R, Díaz-Garrido N, Badia J, Baldomà L.

BMC Microbiol. 2019 Jul 17;19(1):166. doi: 10.1186/s12866-019-1534-3.

19.

Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy.

Zuazo M, Arasanz H, Fernández-Hinojal G, García-Granda MJ, Gato M, Bocanegra A, Martínez M, Hernández B, Teijeira L, Morilla I, Lecumberri MJ, Fernández de Lascoiti A, Vera R, Kochan G, Escors D.

EMBO Mol Med. 2019 Jul;11(7):e10293. doi: 10.15252/emmm.201910293. Epub 2019 Jun 6.

20.

Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.

Arrazubi V, Mata E, Antelo ML, Tarifa A, Herrera J, Zazpe C, Teijeira L, Viudez A, Suárez J, Hernández I, Vera R.

Ann Surg Oncol. 2019 Sep;26(9):2805-2811. doi: 10.1245/s10434-019-07503-8. Epub 2019 Jun 17.

PMID:
31209673
21.

Increased incidences of noninfectious comorbidities among aging populations living with human immunodeficiency virus in Ecuador: a multicenter retrospective analysis.

Hernández I, Barzallo J, Beltrán S, Castillo A, Cevallos N, Hernández P, López C, Vera R, Yerovi G, Mendoza A, Terán S, Izurieta A, Teran E.

HIV AIDS (Auckl). 2019 Apr 1;11:55-59. doi: 10.2147/HIV.S193412. eCollection 2019.

22.

First Report on a Solvent-Free Preparation of Polymer Inclusion Membranes with an Ionic Liquid.

Vera R, Anticó E, Eguiazábal JI, Aranburu N, Fontàs C.

Molecules. 2019 May 14;24(10). pii: E1845. doi: 10.3390/molecules24101845.

23.

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer.

Bocanegra A, Fernandez-Hinojal G, Zuazo-Ibarra M, Arasanz H, Garcia-Granda MJ, Hernandez C, Ibañez M, Hernandez-Marin B, Martinez-Aguillo M, Lecumberri MJ, Fernandez de Lascoiti A, Teijeira L, Morilla I, Vera R, Escors D, Kochan G.

Int J Mol Sci. 2019 Apr 2;20(7). pii: E1631. doi: 10.3390/ijms20071631.

24.

TGF-β/PI3K/AKT/mTOR/NF-kB pathway. Clinicopathological features in prostate cancer.

Torrealba N, Vera R, Fraile B, Martínez-Onsurbe P, Paniagua R, Royuela M.

Aging Male. 2019 Apr 11:1-11. doi: 10.1080/13685538.2019.1597840. [Epub ahead of print]

PMID:
30973040
25.

Correction to: Recommendations for follow‑up of colorectal cancer survivors.

Vera R, Aparicio J, Carballo F, Esteva M, González-Flores E, Santianes J, Santolaya F, Fernández-Cebrián JM.

Clin Transl Oncol. 2019 Oct;21(10):1440. doi: 10.1007/s12094-019-02088-w.

PMID:
30924092
26.

Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review.

Grande E, Díaz Á, López C, Munarriz J, Reina JJ, Vera R, Bernárdez B, Aller J, Capdevila J, Garcia-Carbonero R, Jimenez Fonseca P, Trapero-Bertran M.

Ther Adv Endocrinol Metab. 2019 Feb 18;10:2042018819828217. doi: 10.1177/2042018819828217. eCollection 2019. Review.

27.

Recommendations for follow-up of colorectal cancer survivors.

Vera R, Aparicio J, Carballo F, Esteva M, González-Flores E, Santianes J, Santolaya F, Fernández-Cebrián JM.

Clin Transl Oncol. 2019 Oct;21(10):1302-1311. doi: 10.1007/s12094-019-02059-1. Epub 2019 Feb 14. Erratum in: Clin Transl Oncol. 2019 Mar 28;:.

PMID:
30762206
28.

Automatic determination of arsenate in drinking water by flow analysis with dual membrane-based separation.

Vera R, Zhang Y, Fontàs C, Almeida MIGS, Anticó E, Cattrall RW, Kolev SD.

Food Chem. 2019 Jun 15;283:232-238. doi: 10.1016/j.foodchem.2018.12.122. Epub 2019 Jan 14.

PMID:
30722866
29.

Systemic immunological biomarkers of clinical responses in immune checkpoint blockade therapies.

Arasanz H, Zuazo M, Vera R, Kochan G, Escors D.

Lung Cancer Manag. 2018 Dec 20;7(3):LMT07. doi: 10.2217/lmt-2018-0014. eCollection 2018 Nov. No abstract available.

30.

Quality of life in elderly breast cancer patients with localized disease receiving endocrine treatment: a prospective study.

Arraras JI, Illarramendi JJ, Manterola A, Asin G, Salgado E, Arrondo P, Dominguez MA, Arrazubi V, Martinez E, Viudez A, de la Cruz S, Vera R.

Clin Transl Oncol. 2019 Sep;21(9):1231-1239. doi: 10.1007/s12094-019-02048-4. Epub 2019 Feb 2.

PMID:
30712234
31.

SEOM guidelines 2018.

Santaballa A, Vera R.

Clin Transl Oncol. 2019 Jan;21(1):1-2. doi: 10.1007/s12094-018-02024-4. Epub 2019 Jan 9. No abstract available.

PMID:
30627983
32.

Antimicrobial properties of a novel copper-based composite coating with potential for use in healthcare facilities.

Montero DA, Arellano C, Pardo M, Vera R, Gálvez R, Cifuentes M, Berasain MA, Gómez M, Ramírez C, Vidal RM.

Antimicrob Resist Infect Control. 2019 Jan 5;8:3. doi: 10.1186/s13756-018-0456-4. eCollection 2019.

33.

Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.

Masjuan J, Salido L, DeFelipe A, Hernández-Antolín R, Fernández-Golfín C, Cruz-Culebras A, Matute C, Vera R, Pérez-Torre P, Zamorano JL.

Eur J Neurol. 2019 May;26(5):816-820. doi: 10.1111/ene.13894. Epub 2019 Jan 28.

PMID:
30586229
34.

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018).

Gómez-España MA, Gallego J, González-Flores E, Maurel J, Páez D, Sastre J, Aparicio J, Benavides M, Feliu J, Vera R.

Clin Transl Oncol. 2019 Jan;21(1):46-54. doi: 10.1007/s12094-018-02002-w. Epub 2018 Dec 18.

35.

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.

Macarulla T, Pazo-Cid R, Guillén-Ponce C, López R, Vera R, Reboredo M, Muñoz Martin A, Rivera F, Díaz Beveridge R, La Casta A, Martín Valadés J, Martínez-Galán J, Ales I, Sastre J, Perea S, Hidalgo M.

J Clin Oncol. 2019 Jan 20;37(3):230-238. doi: 10.1200/JCO.18.00089. Epub 2018 Dec 4.

PMID:
30523758
36.

Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study.

Fernández A, Salgado M, García A, Buxò E, Vera R, Adeva J, Jiménez-Fonseca P, Quintero G, Llorca C, Cañabate M, López LJ, Muñoz A, Ramírez P, González P, López C, Reboredo M, Gallardo E, Sanchez-Cánovas M, Gallego J, Guillén C, Ruiz-Miravet N, Navarro-Pérez V, De la Cámara J, Alés-Díaz I, Pazo-Cid RA, Carmona-Bayonas A.

BMC Cancer. 2018 Nov 29;18(1):1185. doi: 10.1186/s12885-018-5101-3.

37.

Cancer Clinical Trials: Treatment Costs Associated With a Spanish National Health System Institution.

Capdevila F, Vera R, Ochoa P, Galbete A, Sanchez-Iriso E.

Ther Innov Regul Sci. 2019 Sep;53(5):641-647. doi: 10.1177/2168479018809692. Epub 2018 Nov 14.

PMID:
30428709
38.
39.

Corrigendum to "Quality of life evolution in elderly survivors with localized breast cancer treated with radiotherapy over a three-year follow-up" [Breast 41 (October 2018) 74-81].

Arraras JI, Manterola A, Illarramendi JJ, Asin G, de la Cruz S, Ibañez B, Galbete A, Salgado E, Zarandona U, Vera R, Dominguez MA, Martinez E.

Breast. 2019 Feb;43:7. doi: 10.1016/j.breast.2018.10.003. Epub 2018 Oct 18. No abstract available.

PMID:
30342259
40.

Optimization of oral chemotherapy in outpatient clinics in Spain: results from a survey of the Spanish Society of Medical Oncology (SEOM).

Santaballa A, De Castro J, Maurel J, Lázaro M, Vera R, Alba E.

Clin Transl Oncol. 2019 Apr;21(4):534-538. doi: 10.1007/s12094-018-1951-z. Epub 2018 Oct 16.

PMID:
30327937
41.

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients.

Vera R, Otero MJ, Ayala de la Peña F, González-Pérez C, Peñuelas Á, Sepúlveda JM, Quer N, Doménech-Climent N, Virizuela JA, Beorlegui P, Gorgas MQ.

Clin Transl Oncol. 2019 Apr;21(4):467-478. doi: 10.1007/s12094-018-1945-x. Epub 2018 Oct 8.

PMID:
30298467
42.

The intracellular signalosome of PD-L1 in cancer cells.

Escors D, Gato-Cañas M, Zuazo M, Arasanz H, García-Granda MJ, Vera R, Kochan G.

Signal Transduct Target Ther. 2018 Sep 28;3:26. doi: 10.1038/s41392-018-0022-9. eCollection 2018. Review.

43.

A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis.

Rodriguez J, Castañón E, Perez-Gracia JL, Rodriguez I, Viudez A, Alfaro C, Oñate C, Perez G, Rotellar F, Inogés S, López-Diaz de Cerio A, Resano L, Ponz-Sarvise M, Rodriguez-Ruiz ME, Chopitea A, Vera R, Melero I.

J Immunother Cancer. 2018 Sep 29;6(1):96. doi: 10.1186/s40425-018-0405-z.

44.

Comparison of different speciation techniques to measure Zn availability in hydroponic media.

Companys E, Galceran J, Puy J, Sedó M, Vera R, Anticó E, Fontàs C.

Anal Chim Acta. 2018 Dec 4;1035:32-43. doi: 10.1016/j.aca.2018.06.071. Epub 2018 Jun 27.

PMID:
30224142
45.

Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists.

Estevez-Fraga C, Molina-Sanchez M, Alvarez-Velasco R, Agüero-Rabes P, Crespo-Araico L, Viedma-Guiard E, Cruz-Culebras A, Matute C, Vera R, De Felipe-Mimbrera A, Masjuan Vallejo J.

Stroke Res Treat. 2018 Aug 2;2018:5613103. doi: 10.1155/2018/5613103. eCollection 2018.

46.

Prediction of protein flexibility using a conformationally restrained contact map.

Vera R, Synsmir-Zizzamia M, Ojinnaka S, Snyder DA.

Proteins. 2018 Oct;86(10):1111-1116. doi: 10.1002/prot.25591. Epub 2018 Oct 5.

PMID:
30099764
47.

[Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer].

Garrido P, Aldaz A, Calleja MÁ, de Álava E, Lamas MJ, Martín M, Matías-Guiu X, Palacios J, Vera R.

Rev Esp Patol. 2018 Jul - Sep;51(3):154-159. doi: 10.1016/j.patol.2017.10.003. Epub 2017 Nov 15. Spanish.

PMID:
30012308
48.

Quality of life evolution in elderly survivors with localized breast cancer treated with radiotherapy over a three-year follow-up.

Arraras JI, Manterola A, Illarramendi JJ, Asin G, de la Cruz S, Ibañez B, Galbete A, Salgado E, Zarandona U, Vera R, Dominguez MA, Martinez E.

Breast. 2018 Oct;41:74-81. doi: 10.1016/j.breast.2018.06.010. Epub 2018 Jun 22. Erratum in: Breast. 2019 Feb;43:7.

PMID:
30007271
49.

Raltitrexed as salvage therapy for metastatic colorectal cancer: A multicenter retrospective study.

Ghanem I, Viudez A, García-Torralba E, Torres-Tenor J, Carmona A, Vera R, Rodriguez-Salas N, de la Peña FA, Higuera O, Feliu J.

Ann Oncol. 2018 Jun;29 Suppl 5:v78. doi: 10.1093/annonc/mdy151.275. Epub 2020 Jan 7. No abstract available.

50.

A new extraction phase based on a polymer inclusion membrane for the detection of chlorpyrifos, diazinon and cyprodinil in natural water samples.

Vera R, Insa S, Fontàs C, Anticó E.

Talanta. 2018 Aug 1;185:291-298. doi: 10.1016/j.talanta.2018.03.056. Epub 2018 Mar 26.

PMID:
29759202

Supplemental Content

Support Center